Tailin Biotech: Net profit expected to increase by 26.32% year-over-year in 2025, with a proposed dividend of 0.3 RMB per 10 shares.

MetaMuskRat · 2026-03-27T16:46:18+00:00

People's Financial News, March 26 — Tailin Bio(300813) disclosed its annual report on March 26. The company achieved operating revenue of 340 million yuan in 2025, a decrease of 2.71% year-on-year; net profit attributable to shareholders of 16.4854 million yuan, a 26.32% increase year-on-year; basic earnings per share of 0.14 yuan. The company plans to distribute a cash dividend of 0.3 yuan (tax included) for every 10 shares to all shareholders.

MetaMuskRat

2026-03-27 16:46:18

People’s Finance News March 26, 泰林生物 (300813) disclosed its annual report on March 26. The company reported operating revenue of RMB 340 million in 2025, down 2.71% year over year; net profit attributable to shareholders of RMB 16.4854 million, up 26.32% year over year; and basic earnings per share of RMB 0.14. The company plans to distribute a cash dividend of RMB 0.3 per 10 shares to all shareholders (including tax).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.